Abstract
A 16-year-old male with severe thrombocytopenia and progressive multiple organ infarctions was diagnosed as having catastrophic antiphospholipid syndrome (CAPS) complicated with systemic lupus erythematosus, and was successfully treated with combination of anticoagulants, corticosteroids, plasma exchange, and intravenous cyclophosphamide. Antibodies to phosphatidylserine/prothrombin (PS/PT) complex and cardiolipin (CL)/β(2)-glycoprotein I (β(2)GPI) were simultaneously detected, indicating that the different pathways of both PS/PT and CL/β(2)GPI might be associated with the radical manifestation of CAPS.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Antibodies, Anticardiolipin / blood
-
Anticoagulants / therapeutic use
-
Antiphospholipid Syndrome / blood
-
Antiphospholipid Syndrome / complications*
-
Antiphospholipid Syndrome / immunology
-
Antiphospholipid Syndrome / therapy
-
Biomarkers / blood
-
Cardiolipins / immunology*
-
Catastrophic Illness
-
Cyclophosphamide / therapeutic use
-
Drug Therapy, Combination
-
Glucocorticoids / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lupus Erythematosus, Systemic / blood
-
Lupus Erythematosus, Systemic / complications*
-
Lupus Erythematosus, Systemic / immunology
-
Lupus Erythematosus, Systemic / therapy
-
Male
-
Phosphatidylserines / blood
-
Phosphatidylserines / immunology*
-
Plasma Exchange
-
Prothrombin / immunology*
-
Prothrombin / metabolism
-
Treatment Outcome
-
beta 2-Glycoprotein I / blood
-
beta 2-Glycoprotein I / immunology*
Substances
-
Antibodies, Anticardiolipin
-
Anticoagulants
-
Biomarkers
-
Cardiolipins
-
Glucocorticoids
-
Immunosuppressive Agents
-
Phosphatidylserines
-
beta 2-Glycoprotein I
-
Cyclophosphamide
-
Prothrombin